Sunbelt Securities Inc. increased its position in shares of Humana Inc. (NYSE:HUM – Free Report) by 150.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 408 shares of the insurance provider’s stock after purchasing an additional 245 shares during the period. Sunbelt Securities Inc.’s holdings in Humana were worth $129,000 at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. Creative Financial Designs Inc. ADV raised its stake in shares of Humana by 244.0% in the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after buying an additional 61 shares in the last quarter. CarsonAllaria Wealth Management Ltd. grew its holdings in Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after acquiring an additional 39 shares during the period. Atwood & Palmer Inc. bought a new stake in Humana in the third quarter worth about $29,000. Ashton Thomas Securities LLC bought a new stake in Humana in the third quarter worth about $31,000. Finally, Your Advocates Ltd. LLP lifted its holdings in Humana by 81.8% in the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after acquiring an additional 45 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several equities analysts have recently issued reports on the stock. Sanford C. Bernstein raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price objective on the stock in a research note on Tuesday, October 8th. Royal Bank of Canada decreased their price target on shares of Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th. Truist Financial cut their price objective on Humana from $400.00 to $260.00 and set a “hold” rating for the company in a research report on Friday, October 11th. Leerink Partnrs cut Humana from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Finally, JPMorgan Chase & Co. upped their target price on Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a report on Wednesday, August 21st. Twenty research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, Humana presently has a consensus rating of “Hold” and an average price target of $304.15.
Humana Stock Up 0.5 %
HUM stock opened at $274.12 on Friday. The company has a 50 day moving average of $274.13 and a two-hundred day moving average of $324.53. The company has a market cap of $33.01 billion, a price-to-earnings ratio of 24.28, a PEG ratio of 2.15 and a beta of 0.53. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $486.00. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67.
Humana (NYSE:HUM – Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The business had revenue of $29.30 billion for the quarter, compared to the consensus estimate of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. On average, equities analysts anticipate that Humana Inc. will post 16.14 earnings per share for the current fiscal year.
Humana Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be paid a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a dividend yield of 1.29%. Humana’s payout ratio is 31.36%.
Humana Company Profile
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Stories
- Five stocks we like better than Humana
- Industrial Products Stocks Investing
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to Read Stock Charts for Beginners
- Texas Instruments: The Old-School Tech Titan Still Delivering
- 3 Grocery Stocks That Are Proving They Are Still Essential
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.